Sponsor:
Medical University of South Carolina
Code:
NCT06035939
Conditions
Sickle Cell Disease
Eligibility Criteria
Sex: All
Age: 14 - 21
Healthy Volunteers: Accepted
Interventions
Voice Crisis Alert V2
Electronic educational materials
Brief summary:
Conditions
Sickle Cell Disease
Study ID
NCT06035939
Start date
Apr 4, 2024
Status verified date
Dec, 2025
Completion date
Jan 31, 2028
Anticipated
Primary completion date
Jul 31, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 14 - 21
Healthy Volunteers: Accepted
Enrollment
272 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Prevention
Arms
experimental: Intervention
active comparator: Control
Interventions
Voice Crisis Alert V2
Electronic educational materials
Primary outcome measure
Central contacts
Locations
Medical University of South Carolina
Recruiting
Charleston, South Carolina, United States, 29425
Contacts
Sponsor
Medical University of South Carolina
Last update posted
Dec 8, 2025
Last verified
Dec, 2025
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Medical University of South Carolina on 2025-12-08.